{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:44:16Z","timestamp":1774561456468,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejso.2019.10.023","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T12:30:22Z","timestamp":1571661022000},"page":"626-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"PA","title":["Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma"],"prefix":"10.1016","volume":"46","author":[{"given":"Martinus C.J.","family":"Anderegg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne S.","family":"Gisbertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel L.G.M.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meindert N.","family":"Sosef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas P.L.","family":"Wijnhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten C.C.M.","family":"Hulshof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques J.G.H.M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.10.023_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2019.10.023_bib2","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1102\/1470-7330.2008.9007","article-title":"Staging esophageal cancer","author":"Quint","year":"2008","journal-title":"Cancer Image"},{"key":"10.1016\/j.ejso.2019.10.023_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jso.23081","article-title":"Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs","volume":"106","author":"Miyata","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","article-title":"7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction","volume":"17","author":"Rice","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5761\/atcs.ra.11.01676","article-title":"Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgery","volume":"17","author":"Makino","year":"2011","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"Suppl 3","key":"10.1016\/j.ejso.2019.10.023_bib7","first-page":"S289","article-title":"Esophageal cancer: staging system and guidelines for staging and treatment","volume":"6","author":"Berry","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.ejso.2019.10.023_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1349-7006.2007.00479.x","article-title":"Treatment of thoracic esophageal carcinoma invading adjacent structures","volume":"98","author":"Seto","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2019.10.023_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00268-004-7590-2","article-title":"Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery","volume":"29","author":"Fujita","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2019.10.023_bib10","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/cncr.26586","article-title":"Failure patterns in patients with esophageal cancer treated with definitive chemoradiation","volume":"118","author":"Welsh","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2019.10.023_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.clon.2012.02.001","article-title":"Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma","volume":"24","author":"Reid","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clon.2010.12.001","article-title":"Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer","volume":"23","author":"Gwynne","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-14-56","article-title":"Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma","volume":"14","author":"Haj Mohammad","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2019.10.023_bib14","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","article-title":"Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus","volume":"17","author":"Ohtsu","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1442-2050.2009.00955.x","article-title":"Salvage esophagectomy after exclusive chemoradiotherapy: results at the Brazilian National Cancer Institute (INCA)","volume":"22","author":"Pinto","year":"2009","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.ejso.2019.10.023_bib16","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.10.023_bib17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/dote.12215","article-title":"Definitive chemoradiation for patients with inoperable and\/or unresectable esophageal cancer: locoregional recurrence pattern","volume":"28","author":"Versteijne","year":"2015","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejso.2019.10.023_bib19","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","article-title":"Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial","volume":"379","author":"Biere","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2019.10.023_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.10.023_bib21","first-page":"2680","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Clinicopathologic correlations. Cancer"},{"key":"10.1016\/j.ejso.2019.10.023_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00268-004-7590-2","article-title":"Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery","volume":"29","author":"Fujita","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2019.10.023_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<25::AID-JSO5>3.0.CO;2-M","article-title":"Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus","volume":"70","author":"Yano","year":"1999","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jso.20640","article-title":"Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion","volume":"95","author":"de Manzoni","year":"2007","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib25","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s00268-013-2074-x","article-title":"Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study","volume":"37","author":"Shimoji","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2019.10.023_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10147-014-0736-9","article-title":"Clinical results of definitive-dose (50 Gy\/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer","volume":"20","author":"Ishikawa","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jso.21235","article-title":"Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer","volume":"99","author":"Miyoshi","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib28","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1245\/s10434-013-2885-x","article-title":"Outcomes associated with surgery for T4 esophageal cancer","volume":"20","author":"Pimiento","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.10.023_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1442-2050.2003.00304.x","article-title":"Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma","volume":"16","author":"Noguchi","year":"2003","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.ejso.2019.10.023_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1442-2050.2001.00184.x","article-title":"Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs","volume":"14","author":"Ikeda","year":"2001","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.ejso.2019.10.023_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijrobp.2009.04.053","article-title":"Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer","volume":"77","author":"D\u00e4hn","year":"2010","journal-title":"Int J Radiat Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319309035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319309035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:52Z","timestamp":1760059972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319309035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0748798319309035"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.10.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}